AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25706340 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost of CC reminder/recall notifications
Number of subjects: 18235
Study 25706340 — intervention group
Group type: COMPARATOR
Intervention: Cost of PB reminder/recall notifications
Number of subjects: 18235
Study 25706340 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted odds ratio for any new immunization in CC vs PB counties
Number of subjects: 18235
Study 25306143 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid palatal expander (RPE)
Number of subjects: 30
Study 25306143 — intervention group
Group type: EXPERIMENTAL
Intervention: McNamara expander
Number of subjects: 30
Study 25306143 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 30
Study 21928901 — intervention group
Group type: EXPERIMENTAL
Intervention: Leisure-only walking
Number of subjects: 16
Study 21928901 — intervention group
Group type: EXPERIMENTAL
Intervention: Utilitarian-only walking
Number of subjects: 16
Study 21928901 — intervention group
Group type: EXPERIMENTAL
Intervention: Freely chosen mixture of leisure and utilitarian walking
Number of subjects: 16
Study 19947568 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexketoprofen trometamol (25 mg, tid) + terazosin (2 mg, qn)
Number of subjects: 115
Study 19947568 — intervention group
Group type: EXPERIMENTAL
Intervention: Indometacin (25 mg, tid) + terazosin (2 mg, qn)
Number of subjects: 115
Study 19947568 — intervention group
Group type: COMPARATOR
Intervention: Terazosin (2 mg, qn)
Number of subjects: 115
Study 17878213 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (0.6 g/kg)
Number of subjects: 32
Study 17878213 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 15246900 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonpolymeric paclitaxel-coated stents
Number of subjects: 0
Study 11981385 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone (80 mg/d for 4 d, then tapered over 8 d) with valacyclovir (1 g, 3 times a day for 10 days)
Number of subjects: 105
Study 11981385 — intervention group
Group type: COMPARATOR
Intervention: Prednisone (80 mg/d for 4 d, then tapered over 8 d) with placebo
Number of subjects: 105
Study 9468240 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 million units (MU) of human lymphoblastoid interferon daily for 4 weeks, followed by 6 MU three times weekly for an additional 22 weeks (total dose, 564 MU)
Number of subjects: 62
Study 9468240 — intervention group
Group type: COMPARATOR
Intervention: 6 MU of interferon three times weekly for an additional 22 weeks (total dose, 564 MU)
Number of subjects: 62
Study 9468240 — intervention group
Group type: COMPARATOR
Intervention: 6 MU of interferon daily for 4 weeks followed by 6 MU three times weekly for 18 weeks (total dose, 660 MU)
Number of subjects: 62
Study 7623388 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine 2 mg
Number of subjects: 125
Study 7623388 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone 35 mg
Number of subjects: 125
Study 7623388 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine 6 mg
Number of subjects: 125
Study 7623388 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone 65 mg
Number of subjects: 125
Study 2012351 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose therapy with trimethoprim-sulfamethoxazole (320-1600 mg)
Number of subjects: 119
Study 2012351 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 days of therapy with trimethoprim-sulfamethoxazole (160-800 mg twice daily)
Number of subjects: 119
Study 2012351 — intervention group
Group type: COMPARATOR
Intervention: No therapy
Number of subjects: 119
Study 2012351 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 days of therapy for patients with upper tract symptoms
Number of subjects: 119
Study 2012351 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose therapy for patients with lower tract symptoms
Number of subjects: 119
Study 2012351 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose therapy for patients less than or equal to 65 years
Number of subjects: 119
Study 2012351 — intervention group
Group type: COMPARATOR
Intervention: No therapy for patients older than 65 years
Number of subjects: 119
Study 2012351 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall resolution in younger women (less than or equal to 65 years)
Number of subjects: 119
Study 2012351 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall resolution in older women (greater than 65 years)
Number of subjects: 119
Study 7046318 — intervention group
Group type: EXPERIMENTAL
Intervention: Sclerosant injection
Number of subjects: 50
Study 7046318 — intervention group
Group type: EXPERIMENTAL
Intervention: Rubber band ligation
Number of subjects: 50
Study 7046318 — intervention group
Group type: COMPARATOR
Intervention: Neither treatment
Number of subjects: 50
Study 31907924 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline 1%
Number of subjects: 270
Study 31907924 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline 3%
Number of subjects: 270
Study 31907924 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 270
Study 30765264 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic adhesiolysis
Number of subjects: 104
Study 30765264 — intervention group
Group type: COMPARATOR
Intervention: Open adhesiolysis
Number of subjects: 104
Study 28905189 — intervention group
Group type: EXPERIMENTAL
Intervention: Bortezomib (1.3 mg/m2) and Dexamethasone (20 mg)
Number of subjects: 96
Study 28905189 — intervention group
Group type: COMPARATOR
Intervention: Bortezomib-Dexamethasone plus Oral Cyclophosphamide (50 mg)
Number of subjects: 96
Study 28905189 — intervention group
Group type: EXPERIMENTAL
Intervention: Bortezomib and Dexamethasone
Number of subjects: 96
Study 28905189 — intervention group
Group type: COMPARATOR
Intervention: Bortezomib-Dexamethasone plus Oral Cyclophosphamide
Number of subjects: 96
Study 28905189 — intervention group
Group type: EXPERIMENTAL
Intervention: Bortezomib-Dexamethasone
Number of subjects: 96
Study 26111665 — intervention group
Group type: EXPERIMENTAL
Intervention: McGRATH MAC laryngoscope (McG group; 25 patients)
Number of subjects: 50
Study 26111665 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope (McL group; 25 patients)
Number of subjects: 50
Study 26111665 — intervention group
Group type: EXPERIMENTAL
Intervention: McGRATH MAC laryngoscope (McG group)
Number of subjects: 50
Study 26111665 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope (McL group)
Number of subjects: 50
Study 23749315 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS (30 min, twice a week for 12 weeks)
Number of subjects: 75
Study 23749315 — intervention group
Group type: COMPARATOR
Intervention: Oxybutynin (daily slow release 10 mg for 12 weeks)
Number of subjects: 75
Study 23749315 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS + Oxybutynin (multimodal treatment for 12 weeks)
Number of subjects: 75
Study 22282770 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised group exercises once a week
Number of subjects: 257
Study 19131461 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined measurement of fasting plasma glucose (FPG) and A1C
Number of subjects: 6736
Study 19131461 — intervention group
Group type: COMPARATOR
Intervention: Fasting plasma glucose (FPG) alone
Number of subjects: 6736
Study 19131461 — intervention group
Group type: COMPARATOR
Intervention: A1C alone
Number of subjects: 6736
Study 17450704 — intervention group
Group type: EXPERIMENTAL
Intervention: Reporting the presence of MBD in the screening mammography results letter along with an information pamphlet
Number of subjects: 618
Study 17450704 — intervention group
Group type: COMPARATOR
Intervention: Control group (no MBD information provided)
Number of subjects: 618
Study 15354105 — intervention group
Group type: EXPERIMENTAL
Intervention: MECC System (group A)
Number of subjects: 100
Study 15354105 — intervention group
Group type: COMPARATOR
Intervention: Standard cardiopulmonary bypass (group B)
Number of subjects: 100
Study 11773686 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary interventions (PCI) with > or =3 stents
Number of subjects: 115
Study 10091202 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral 17 beta‐estradiol, 2 mg/day for 3 months
Number of subjects: 33
Study 10091202 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 33
Study 7808029 — intervention group
Group type: EXPERIMENTAL
Intervention: ATRA and intensive chemotherapy
Number of subjects: 0
Study 7808029 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 0
Study 2569486 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine (40 mg) with concurrent high potency antacid
Number of subjects: 0
Study 2569486 — intervention group
Group type: COMPARATOR
Intervention: Famotidine (40 mg) with antacid ingested 2 hours after administration
Number of subjects: 0
Study 76394 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-methasone valerate 0.1%
Number of subjects: 7
Study 76394 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-methasone valerate 1.0%
Number of subjects: 7
Study 76394 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone butyrate 0.1% with plastic occlusion
Number of subjects: 7
Study 76394 — intervention group
Group type: COMPARATOR
Intervention: Placebo creams
Number of subjects: 7
Study 31842232 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute care at home
Number of subjects: 91
Study 30044291 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane (1.0% starting concentration, adjusted by 0.2% step size)
Number of subjects: 20
Study 30044291 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal renal function, 21 patients)
Number of subjects: 20
Study 30044291 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal renal function)
Number of subjects: 20
Study 30044291 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with ESRD
Number of subjects: 20
Study 28396046 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 27
Study 28396046 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 28396046 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic saline (HS) injections
Number of subjects: 27
Study 25791513 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening arm (PSA-based screening)
Number of subjects: 13515
Study 25791513 — intervention group
Group type: COMPARATOR
Intervention: Control arm (no screening)
Number of subjects: 13515
Study 23736093 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium 0.6 mg/kg
Number of subjects: 288
Study 23736093 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium 1.2 mg/kg
Number of subjects: 288
Study 21221991 — intervention group
Group type: EXPERIMENTAL
Intervention: Taekwondo training
Number of subjects: 22
Study 21221991 — intervention group
Group type: COMPARATOR
Intervention: Operator-triggered drops
Number of subjects: 22
Study 19217212 — intervention group
Group type: EXPERIMENTAL
Intervention: Unresolved trauma in abused women
Number of subjects: 44
Study 19217212 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental stress challenge (TSST)
Number of subjects: 44
Study 17944785 — intervention group
Group type: EXPERIMENTAL
Intervention: Incredible Years (IY) Basic parent training (PT) programme
Number of subjects: 0
Study 17944785 — intervention group
Group type: COMPARATOR
Intervention: Waiting list (WL) control group
Number of subjects: 0
Study 15588037 — intervention group
Group type: EXPERIMENTAL
Intervention: Diskus
Number of subjects: 15
Study 15588037 — intervention group
Group type: EXPERIMENTAL
Intervention: Turbuhaler
Number of subjects: 15
Study 15588037 — intervention group
Group type: EXPERIMENTAL
Intervention: pMDI
Number of subjects: 15
Study 15588037 — intervention group
Group type: EXPERIMENTAL
Intervention: Volumatic
Number of subjects: 15
Study 11247619 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured problem solving
Number of subjects: 0
Study 11247619 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective serotonin reuptake inhibitor (SSRI) medication
Number of subjects: 0
Study 9812648 — intervention group
Group type: EXPERIMENTAL
Intervention: Glibenclamide + Kelening
Number of subjects: 65
Study 9812648 — intervention group
Group type: COMPARATOR
Intervention: Glibenclamide
Number of subjects: 65
Study 7963870 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic stockings worn for four weeks (Group A)
Number of subjects: 20
Study 7963870 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic stockings worn for four weeks (Group B)
Number of subjects: 20
Study 7963870 — intervention group
Group type: COMPARATOR
Intervention: Control (removal of stockings)
Number of subjects: 20
Study 3311571 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol
Number of subjects: 10
Study 3311571 — intervention group
Group type: COMPARATOR
Intervention: Control drink (isocaloric glucose)
Number of subjects: 10
Study 31478556 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-Fr sheath
Number of subjects: 214
Study 31478556 — intervention group
Group type: COMPARATOR
Intervention: 7-Fr sheath
Number of subjects: 214
Study 31843232 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower serum albumin levels
Number of subjects: 3254
Study 29602978 — intervention group
Group type: COMPARATOR
Intervention: Diane‐35 alone (D group)
Number of subjects: 240
Study 29602978 — intervention group
Group type: EXPERIMENTAL
Intervention: Diane‐35 plus orlistat (DO group)
Number of subjects: 240
Study 29602978 — intervention group
Group type: EXPERIMENTAL
Intervention: Diane‐35 plus metformin (DM group)
Number of subjects: 240
Study 29602978 — intervention group
Group type: EXPERIMENTAL
Intervention: Diane‐35 plus orlistat plus metformin (DOM group)
Number of subjects: 240
Study 27825638 — intervention group
Group type: COMPARATOR
Intervention: Erlotinib (150 mg)
Number of subjects: 125
Study 27825638 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabozantinib (60 mg)
Number of subjects: 125
Study 27825638 — intervention group
Group type: EXPERIMENTAL
Intervention: Erlotinib plus Cabozantinib (150 mg + 40 mg)
Number of subjects: 125
Study 25138333 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained care (n = 198) with automated interactive voice response telephone calls and choice of free smoking cessation medication for up to 90 days
Number of subjects: 397
Study 25138333 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained care (n = 198)
Number of subjects: 397
Study 25138333 — intervention group
Group type: COMPARATOR
Intervention: Standard care (n = 199)
Number of subjects: 397
Study 23746142 — intervention group
Group type: EXPERIMENTAL
Intervention: cRFA followed by interferon (IFN)‐α, 9 MIU, s.c., three times per week (Study 1)
Number of subjects: 114
Study 23746142 — intervention group
Group type: EXPERIMENTAL
Intervention: cRFA followed by sunitinib in repeated 6‐week cycles of 50 mg/day orally for 4 weeks, then 2 weeks off treatment (Study 2)
Number of subjects: 114
Study 23746142 — intervention group
Group type: EXPERIMENTAL
Intervention: sunitinib alone (Study 3)
Number of subjects: 114
Study 21943128 — intervention group
Group type: EXPERIMENTAL
Intervention: Developed countries
Number of subjects: 28
Study 21943128 — intervention group
Group type: EXPERIMENTAL
Intervention: Developing countries
Number of subjects: 28
Study 18356205 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 114
Study 16328419 — intervention group
Group type: EXPERIMENTAL
Intervention: Stellar ganglion blockade by diadynamic current in Group II
Number of subjects: 30
Study 16328419 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy and exercise with physical therapy agents in both groups
Number of subjects: 30
Study 12755841 — intervention group
Group type: EXPERIMENTAL
Intervention: lansoprazole-clarithromycin-metronidazole
Number of subjects: 88
Study 12755841 — intervention group
Group type: COMPARATOR
Intervention: lansoprazole-clarithromycin-amoxicillin
Number of subjects: 88
Study 11219963 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam (0.125 mg/70 kg)
Number of subjects: 24
Study 11219963 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam (0.25 mg/70 kg)
Number of subjects: 24
Study 11219963 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 8637993 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral CT contrast agents
Number of subjects: 30
Study 1453208 — intervention group
Group type: EXPERIMENTAL
Intervention: Hickman catheter
Number of subjects: 100
Study 1453208 — intervention group
Group type: COMPARATOR
Intervention: Port‐a‐Cath
Number of subjects: 100
Study 3905061 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 0
Study 3905061 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 0
Study 30778858 — intervention group
Group type: EXPERIMENTAL
Intervention: PINQ-PHONE questionnaire
Number of subjects: 769
Study 30829159 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive tools provided to 46 practices
Number of subjects: 88
Study 30829159 — intervention group
Group type: COMPARATOR
Intervention: Control group (42 practices without intervention)
Number of subjects: 88
Study 26349600 — intervention group
Group type: EXPERIMENTAL
Intervention: D-cycloserine (DCS)
Number of subjects: 110
Study 26349600 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention Bias Modification (ABM)
Number of subjects: 110
Study 26349600 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 110
Study 26349600 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective Serotonin Reuptake Inhibitors (SSRIs)
Number of subjects: 110
Study 25514303 — intervention group
Group type: EXPERIMENTAL
Intervention: High-glycemic index, high-carbohydrate diet (65% on glucose scale, 58% energy)
Number of subjects: 163
Study 25514303 — intervention group
Group type: COMPARATOR
Intervention: Low-glycemic index, high-carbohydrate diet (40%)
Number of subjects: 163
Study 25514303 — intervention group
Group type: COMPARATOR
Intervention: High-glycemic index, low-carbohydrate diet (40% energy)
Number of subjects: 163
Study 25514303 — intervention group
Group type: COMPARATOR
Intervention: Low-glycemic index, low-carbohydrate diet
Number of subjects: 163
Study 22462635 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous bone marrow-derived cells (BMCs) transplantation
Number of subjects: 27
Study 20410089 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 long-chain polyunsaturated fatty acid supplementation (200 mg EPA plus 500 mg DHA)
Number of subjects: 867
Study 20410089 — intervention group
Group type: COMPARATOR
Intervention: Olive oil (placebo)
Number of subjects: 867
Study 18683786 — intervention group
Group type: EXPERIMENTAL
Intervention: COPD group
Number of subjects: 19
Study 16231596 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Treatment Group (n=5 students) received the basic module 'ADHD theory and school-based interventions' (6 h)
Number of subjects: 11
Study 16231596 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Treatment Group (n=6 students) received the basic module plus 'Student-related training in Contingency Management' (total 14h)
Number of subjects: 11
Study 11874767 — intervention group
Group type: EXPERIMENTAL
Intervention: Inoveon Diabetic Retinopathy (DR‐3DT) system
Number of subjects: 290
Study 11874767 — intervention group
Group type: COMPARATOR
Intervention: Film 'gold standard'
Number of subjects: 290
Study 10094218 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (500 microg twice daily) via Diskus
Number of subjects: 213
Study 10094218 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 213
Study 10094218 — intervention group
Group type: EXPERIMENTAL
Intervention: Diskus and Diskhaler
Number of subjects: 213
Study 10094218 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate
Number of subjects: 213
Study 7489431 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycopyrrolate
Number of subjects: 121
Study 7489431 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine
Number of subjects: 121
Study 7489431 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study 2185810 — intervention group
Group type: EXPERIMENTAL
Intervention: Capitation system of remuneration
Number of subjects: 0
Study 2185810 — intervention group
Group type: COMPARATOR
Intervention: Fee-for-service
Number of subjects: 0
Study 24512 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphenhydramine 50 mg intravenously
Number of subjects: 6
Study 24512 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphenhydramine 50 mg orally
Number of subjects: 6
Study 24512 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 24512 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphenhydramine (both IV and oral)
Number of subjects: 6
Study 31770296 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin (2 mg/kg twice daily for 5 days post-surgery)
Number of subjects: 63
Study 31770296 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 30601819 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric cycling training
Number of subjects: 23
Study 30601819 — intervention group
Group type: COMPARATOR
Intervention: Concentric cycling training
Number of subjects: 23
Study 28771386 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental stress at baseline (for children 16 years or older)
Number of subjects: 0
Study 28771386 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased child-rated parental protectiveness (for children less than 16 years old)
Number of subjects: 0
Study 28771386 — intervention group
Group type: EXPERIMENTAL
Intervention: Low parental monitoring and supervision
Number of subjects: 0
Study 28771386 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental history of conduct disorder
Number of subjects: 0
Study 26552756 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) with drug-eluting stents (DES)
Number of subjects: 1800
Study 26552756 — intervention group
Group type: COMPARATOR
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 1800
Study 23122829 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 110
Study 23122829 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study 21592721 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted surgery
Number of subjects: 120
Study 21592721 — intervention group
Group type: COMPARATOR
Intervention: Nonassisted surgery
Number of subjects: 120